Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal-associated brain damage: A pilot study.
Clergue-Duval V, Vrillon A, Jeanblanc J, Questel F, Azuar J, Fouquet G, Mouton-Liger F, Rollet D, Hispard E, Bouaziz-Amar E, Bloch V, Dereux A, Cognat E, Marie-Claire C, Laplanche JL, Bellivier F, Paquet C, Naassila M, Vorspan F. Clergue-Duval V, et al. Among authors: bouaziz amar e. Addict Biol. 2022 Nov;27(6):e13232. doi: 10.1111/adb.13232. Addict Biol. 2022. PMID: 36301211
Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study.
Paquet C, Magnin E, Wallon D, Troussière AC, Dumurgier J, Jager A, Bellivier F, Bouaziz-Amar E, Blanc F, Beaufils E, Miguet-Alfonsi C, Quillard M, Schraen S, Pasquier F, Hannequin D, Robert P, Hugon J, Mouton-Liger F; For ePLM network and collaborators. Paquet C, et al. Alzheimers Res Ther. 2016 Jun 13;8:27. doi: 10.1186/s13195-016-0192-z. Alzheimers Res Ther. 2016. PMID: 27357952 Free PMC article.
Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers.
Vercruysse O, Paquet C, Gabelle A, Delbeuck X, Blanc F, Wallon D, Dumurgier J, Magnin E, Martinaud O, Jung B, Bousiges O, Lehmann S, Delaby C, Quillard-Murain M, Peoc H K, Laplanche JL, Bouaziz-Amar E, Hannequin D, Sablonniere B, Buee L, Hugon J, Schraen S, Pasquier F, Bombois S, For The E-Plm Group. Vercruysse O, et al. Curr Alzheimer Res. 2018;15(7):691-700. doi: 10.2174/1567205015666180110113238. Curr Alzheimer Res. 2018. PMID: 29318973
CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease.
Boumenir A, Cognat E, Sabia S, Hourregue C, Lilamand M, Dugravot A, Bouaziz-Amar E, Laplanche JL, Hugon J, Singh-Manoux A, Paquet C, Dumurgier J. Boumenir A, et al. Alzheimers Res Ther. 2019 Mar 28;11(1):29. doi: 10.1186/s13195-019-0481-4. Alzheimers Res Ther. 2019. PMID: 30922415 Free PMC article.
Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice.
Lehmann S, Paquet C, Malaplate-Armand C, Magnin E, Schraen S, Quillard-Muraine M, Bousiges O, Delaby C, Dumurgier J, Hugon J, Sablonnière B, Blanc F, Wallon D, Gabelle A, Laplanche JL, Bouaziz-Amar E, Peoc'h K; ePLM Group. Lehmann S, et al. Clin Chim Acta. 2019 Aug;495:451-456. doi: 10.1016/j.cca.2019.04.081. Epub 2019 Apr 30. Clin Chim Acta. 2019. PMID: 31051163
What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.
Cognat E, Mouton Liger F, Troussière AC, Wallon D, Dumurgier J, Magnin E, Duron E, Gabelle A, Croisile B, de la Sayette V, Jager A, Blanc F, Bouaziz-Amar E, Miguet-Alfonsi C, Quillard M, Schraen S, Philippi N, Beaufils E, Pasquier F, Hannequin D, Robert P, Hugon J, Paquet C; ePLM network. Cognat E, et al. BMJ Open. 2019 May 30;9(5):e026380. doi: 10.1136/bmjopen-2018-026380. BMJ Open. 2019. PMID: 31152032 Free PMC article.
44 results